Since 2011, NCCN has worked with the Latin American Cooperative Oncology Group (LACOG) to develop Latin America Editions of the NCCN Guidelines for Breast, Colon, Non-Small Cell Lung, Prostate Cancer, Multiple Myeloma, and Rectal Cancers. LACOG is a non-profit organization founded in 2008 by a group of Latin American medical oncologists interested in the development of academic clinical research. LACOG is the first multinational cooperative group in Latin America exclusively dedicated to clinical and translational research in cancer.
In 2021, NCCN embarked on a comprehensive new project to impact access to evidence-based care for prostate cancer in the LATAM region. In collaboration with LACOG, NCCN co-hosted a webinar with leading experts from Latin America and the United States focused on key updates in the NCCN Guidelines for Prostate Cancer to optimize clinical management. Furthermore, to increase accessibility to NCCN Guidelines for non-English speaking providers, patients, family members, and caregivers in the LATAM region, NCCN translated both the clinical and patient guidelines for prostate cancer into Spanish and Portuguese.